Human Insulin Market by Product Types & Brand -2019

1
MarketsandMarkets Presents
Human Insulin Market by Product Types Brand
-2019
http//www.marketsandmarkets.com/Market-Reports/hu
man-insulin-market-229295783.html
2
The Human Insulin Market by Product Type Human
Insulin (Short Acting, Intermediate Acting,
Premixed), Modern Human Insulin (Rapid Acting,
Long Acting, Premixed), by Brand (Lantus,
Apidra, Levemir, NovoRapid, Novomix, Tresiba,
Others) - Forecast to 2019provides a detailed
overview of the major drivers,restraints,
challenges, opportunities, current market
trends,and strategies impacting the global human
insulin market along with the estimates and
forecasts of the revenue and share
analysis. Browse 112 market data tables and 43
figures spread through 250 pages and in-depth TOC
on "Human Insulin Market "http//www.marketsandma
rkets.com/Market-Reports/human-insulin-market-2292
95783.html Early buyers will receive 10
customization in this report. The global human
insulin market crossed 23 billion in 2013 and is
poised to grow at a high double-digit CAGR from
2014 to 2019.
http//www.marketsandmarkets.com/Market-Reports/hu
man-insulin-market-229295783.html
3
The human insulin market is segmented based on
types of insulin, and branded drugs available in
the market. The two major classifications of
human insulin are traditional and modern human
insulin. Further traditional human insulin is
divided into three types- short acting,
intermediate acting, and premixed traditional
human insulin. Modern human insulin is
fragmented into long acting, rapid acting, and
premixed modern human insulin. Of all, premixed
and long acting modern human insulin will be the
two fastest growing markets in the given forecast
period. Speak to Analyst http//www.marketsandma
rkets.com/speaktoanalyst.asp?id229295783
http//www.marketsandmarkets.com/Market-Reports/hu
man-insulin-market-229295783.html
4
The biologics/branded insulin considered for this
study are Apidra, Actrapid, Humalog, Humulin,
Insuman, Insulatard, Lantus, Levemir, Mixtard,
Novomix, Novorapid, and Tresiba. The three
biosimilars available in the Asian countries and
RoW are Wosulin (Wockhardt), Basalog (Biocon),
and Glaritus (Wockhardt). In comparison to
branded drugs, biosimilar, a similar version of
branded biologics, will be the faster growing
market in the next five years. Among all
available brands, Lantus (Insulin Glargine)
accounted for the largest share in the market
whereas Apidra and Levemir will be the fastest
growing drugs in the forecast period. Request
for Customization of Report http//www.marketsand
markets.com/requestCustomization.asp?id229295783

http//www.marketsandmarkets.com/Market-Reports/hu
man-insulin-market-229295783.html
5
The major bottlenecks for the growth of the
market are stringent and complex regulatory
guidelines that delay the approval process of new
drugs as well as high manufacturing complexities
and cost associated in the development of human
insulin. North America is the largest
contributor to the global market whileAsia is
expected to grow at the highest rate. Asia
(China, and India), Middle East (Saudi Arabia,
Egypt, Qatar, U.A.E), and Latin America (Brazil,
Mexico) are also poised to grow at double-digit
CAGRs in the coming years. The key players in
the market are Novo Nordisk (Denmark), Eli Lilly
(U.S), Sanofi Aventis(France),Biocon (India),
Julphar(U.A.E),Wockhardt (India),SemBioSys
(Canada), and GSK (U.K.). Buy Now http//www.mar
ketsandmarkets.com/Purchase/purchase_report1.asp?i
d229295783
http//www.marketsandmarkets.com/Market-Reports/hu
man-insulin-market-229295783.html
6
About MarketsandMarkets MarketsandMarkets is a
global market research and consulting company
based in the U.S. We publish strategically
analyzed market research reports and serve as a
business intelligence partner to Fortune 500
companies across the world. MarketsandMarkets
also provides multi-client reports, company
profiles, databases, and custom research
services. MarketsandMarkets covers thirteen
industry verticals, including advanced materials,
automotive and transportation, banking and
financial services, biotechnology, chemicals,
consumer goods, energy and power, food and
beverages, industrial automation, medical
devices, pharmaceuticals, semiconductor and
electronics, and telecommunications and IT. We
at MarketsandMarkets are inspired to help our
clients grow by providing apt business insight
with our huge market intelligence repository.
http//www.marketsandmarkets.com/Market-Reports/hu
man-insulin-market-229295783.html
7
Contact Us
Mr. Rohan North - Dominion Plaza, 17304 Preston
Road, Suite 800, Dallas, TX 75252Tel
1-888-6006-441     Email sales_at_marketsandmarket
s.com MarketsandMarkets Bloghttp//www.marketsan
dmarkets.comhttp//twitter.com/marketsmarkets htt
p//www.linkedin.com/company/marketsandmarkets